3.10.0.1 html 146 216 1 false 48 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://biohavenpharma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://biohavenpharma.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://biohavenpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://biohavenpharma.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://biohavenpharma.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 2101100 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://biohavenpharma.com/role/NatureOfBusinessAndBasisOfPresentation Nature of the Business and Basis of Presentation Notes 6 false false R7.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://biohavenpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2103100 - Disclosure - Fair Value of Financial Assets and Liabilities Sheet http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilities Fair Value of Financial Assets and Liabilities Notes 8 false false R9.htm 2104100 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://biohavenpharma.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 2105100 - Disclosure - Equity Method Investment Sheet http://biohavenpharma.com/role/EquityMethodInvestment Equity Method Investment Notes 10 false false R11.htm 2106100 - Disclosure - Accrued Expenses Sheet http://biohavenpharma.com/role/AccruedExpenses Accrued Expenses Notes 11 false false R12.htm 2107100 - Disclosure - Liability Related to Sale of Future Royalties Sheet http://biohavenpharma.com/role/LiabilityRelatedToSaleOfFutureRoyalties Liability Related to Sale of Future Royalties Notes 12 false false R13.htm 2108100 - Disclosure - Warrants Sheet http://biohavenpharma.com/role/Warrants Warrants Notes 13 false false R14.htm 2109100 - Disclosure - Convertible Preferred Shares Sheet http://biohavenpharma.com/role/ConvertiblePreferredShares Convertible Preferred Shares Notes 14 false false R15.htm 2110100 - Disclosure - Shareholders' Equity Sheet http://biohavenpharma.com/role/ShareholdersEquity Shareholders' Equity Notes 15 false false R16.htm 2111100 - Disclosure - Net Loss per Share Sheet http://biohavenpharma.com/role/NetLossPerShare Net Loss per Share Notes 16 false false R17.htm 2112100 - Disclosure - License and Other Agreements Sheet http://biohavenpharma.com/role/LicenseAndOtherAgreements License and Other Agreements Notes 17 false false R18.htm 2113100 - Disclosure - Commitments and Contingencies Sheet http://biohavenpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 2114100 - Disclosure - Related Party Transactions Sheet http://biohavenpharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://biohavenpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://biohavenpharma.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 2303301 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) Sheet http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables Fair Value of Financial Assets and Liabilities (Tables) Tables http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilities 21 false false R22.htm 2304301 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://biohavenpharma.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://biohavenpharma.com/role/PrepaidExpensesAndOtherCurrentAssets 22 false false R23.htm 2305301 - Disclosure - Equity Method Investment (Tables) Sheet http://biohavenpharma.com/role/EquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://biohavenpharma.com/role/EquityMethodInvestment 23 false false R24.htm 2306301 - Disclosure - Accrued Expenses (Tables) Sheet http://biohavenpharma.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://biohavenpharma.com/role/AccruedExpenses 24 false false R25.htm 2307301 - Disclosure - Liability Related to Sale of Future Royalties (Tables) Sheet http://biohavenpharma.com/role/LiabilityRelatedToSaleOfFutureRoyaltiesTables Liability Related to Sale of Future Royalties (Tables) Tables http://biohavenpharma.com/role/LiabilityRelatedToSaleOfFutureRoyalties 25 false false R26.htm 2308301 - Disclosure - Warrants (Tables) Sheet http://biohavenpharma.com/role/WarrantsTables Warrants (Tables) Tables http://biohavenpharma.com/role/Warrants 26 false false R27.htm 2310301 - Disclosure - Shareholders' Equity (Tables) Sheet http://biohavenpharma.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://biohavenpharma.com/role/ShareholdersEquity 27 false false R28.htm 2311301 - Disclosure - Net Loss per Share (Tables) Sheet http://biohavenpharma.com/role/NetLossPerShareTables Net Loss per Share (Tables) Tables http://biohavenpharma.com/role/NetLossPerShare 28 false false R29.htm 2313301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://biohavenpharma.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://biohavenpharma.com/role/CommitmentsAndContingencies 29 false false R30.htm 2401401 - Disclosure - Nature of the Business and Basis of Presentation - Initial Public Offering (Details) Sheet http://biohavenpharma.com/role/NatureOfBusinessAndBasisOfPresentationInitialPublicOfferingDetails Nature of the Business and Basis of Presentation - Initial Public Offering (Details) Details 30 false false R31.htm 2401402 - Disclosure - Nature of the Business and Basis of Presentation - Going Concern (Details) Sheet http://biohavenpharma.com/role/NatureOfBusinessAndBasisOfPresentationGoingConcernDetails Nature of the Business and Basis of Presentation - Going Concern (Details) Details 31 false false R32.htm 2403402 - Disclosure - Fair Value of Financial Assets and Liabilities - Measured on a Recurring Basis (Details) Sheet http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Fair Value of Financial Assets and Liabilities - Measured on a Recurring Basis (Details) Details 32 false false R33.htm 2403403 - Disclosure - Fair Value of Financial Assets and Liabilities - Narrative (Details) Sheet http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilitiesNarrativeDetails Fair Value of Financial Assets and Liabilities - Narrative (Details) Details 33 false false R34.htm 2403404 - Disclosure - Fair Value of Financial Assets and Liabilities - Rollforward of Liabilities Measured by Level 3 Inputs (Details) Sheet http://biohavenpharma.com/role/FairValueOfFinancialAssetsAndLiabilitiesRollforwardOfLiabilitiesMeasuredByLevel3InputsDetails Fair Value of Financial Assets and Liabilities - Rollforward of Liabilities Measured by Level 3 Inputs (Details) Details 34 false false R35.htm 2404402 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://biohavenpharma.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://biohavenpharma.com/role/PrepaidExpensesAndOtherCurrentAssetsTables 35 false false R36.htm 2405402 - Disclosure - Equity Method Investment - Stock Purchase Agreement with Kleo (Details) Sheet http://biohavenpharma.com/role/EquityMethodInvestmentStockPurchaseAgreementWithKleoDetails Equity Method Investment - Stock Purchase Agreement with Kleo (Details) Details 36 false false R37.htm 2405403 - Disclosure - Equity Method Investment - Proportionate Share of Net Loss (Details) Sheet http://biohavenpharma.com/role/EquityMethodInvestmentProportionateShareOfNetLossDetails Equity Method Investment - Proportionate Share of Net Loss (Details) Details 37 false false R38.htm 2405404 - Disclosure - Equity Method Investment - Carrying Value (Details) Sheet http://biohavenpharma.com/role/EquityMethodInvestmentCarryingValueDetails Equity Method Investment - Carrying Value (Details) Details 38 false false R39.htm 2406402 - Disclosure - Accrued Expenses (Details) Sheet http://biohavenpharma.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://biohavenpharma.com/role/AccruedExpensesTables 39 false false R40.htm 2407402 - Disclosure - Liability Related to Sale of Future Royalties - Narrative (Details) Sheet http://biohavenpharma.com/role/LiabilityRelatedToSaleOfFutureRoyaltiesNarrativeDetails Liability Related to Sale of Future Royalties - Narrative (Details) Details 40 false false R41.htm 2407403 - Disclosure - Liability Related to Sale of Future Royalties - Carrying Value and Related Activity (Details) Sheet http://biohavenpharma.com/role/LiabilityRelatedToSaleOfFutureRoyaltiesCarryingValueAndRelatedActivityDetails Liability Related to Sale of Future Royalties - Carrying Value and Related Activity (Details) Details 41 false false R42.htm 2408402 - Disclosure - Warrants - Credit Agreement (Details) Sheet http://biohavenpharma.com/role/WarrantsCreditAgreementDetails Warrants - Credit Agreement (Details) Details 42 false false R43.htm 2408403 - Disclosure - Warrants - Guarantor and Co-Guarantor Warrants (Details) Sheet http://biohavenpharma.com/role/WarrantsGuarantorAndCoGuarantorWarrantsDetails Warrants - Guarantor and Co-Guarantor Warrants (Details) Details 43 false false R44.htm 2409401 - Disclosure - Convertible Preferred Shares (Details) Sheet http://biohavenpharma.com/role/ConvertiblePreferredSharesDetails Convertible Preferred Shares (Details) Details http://biohavenpharma.com/role/ConvertiblePreferredShares 44 false false R45.htm 2410402 - Disclosure - Shareholders' Equity - Changes in Shareholders' Equity (Details) Sheet http://biohavenpharma.com/role/ShareholdersEquityChangesInShareholdersEquityDetails Shareholders' Equity - Changes in Shareholders' Equity (Details) Details 45 false false R46.htm 2410403 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://biohavenpharma.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 46 false false R47.htm 2411402 - Disclosure - Net Loss per Share - Calculation of Basic and Diluted Net Loss per Share (Details) Sheet http://biohavenpharma.com/role/NetLossPerShareCalculationOfBasicAndDilutedNetLossPerShareDetails Net Loss per Share - Calculation of Basic and Diluted Net Loss per Share (Details) Details 47 false false R48.htm 2411403 - Disclosure - Net Loss per Share - Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) Sheet http://biohavenpharma.com/role/NetLossPerShareAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails Net Loss per Share - Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) Details 48 false false R49.htm 2412401 - Disclosure - License and Other Agreements (Details) Sheet http://biohavenpharma.com/role/LicenseAndOtherAgreementsDetails License and Other Agreements (Details) Details http://biohavenpharma.com/role/LicenseAndOtherAgreements 49 false false R50.htm 2412402 - Disclosure - License and Other Agreements - Revenue Participation Rights with RPI Finance Trust (Details) Sheet http://biohavenpharma.com/role/LicenseAndOtherAgreementsRevenueParticipationRightsWithRpiFinanceTrustDetails License and Other Agreements - Revenue Participation Rights with RPI Finance Trust (Details) Details 50 false false R51.htm 2412403 - Disclosure - License and Other Agreements - License Agreement with AstraZeneca (Details) Sheet http://biohavenpharma.com/role/LicenseAndOtherAgreementsLicenseAgreementWithAstrazenecaDetails License and Other Agreements - License Agreement with AstraZeneca (Details) Details 51 false false R52.htm 2413402 - Disclosure - Commitments and Contingencies - Lease Agreements and License Agreements (Details) Sheet http://biohavenpharma.com/role/CommitmentsAndContingenciesLeaseAgreementsAndLicenseAgreementsDetails Commitments and Contingencies - Lease Agreements and License Agreements (Details) Details 52 false false R53.htm 2414401 - Disclosure - Related Party Transactions (Details) Sheet http://biohavenpharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://biohavenpharma.com/role/RelatedPartyTransactions 53 false false All Reports Book All Reports a2018q3bhvn10-q.htm a2018q3bhvn10-qexhibit101.htm a2018q3bhvn10-qexhibit311.htm a2018q3bhvn10-qexhibit312.htm a2018q3bhvn10-qexhibit321.htm bhvn-20180930.xsd bhvn-20180930_cal.xml bhvn-20180930_def.xml bhvn-20180930_lab.xml bhvn-20180930_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true